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TO THE EDITOR
Epidermolytic hyperkeratosis (EHK),
also called bullous congenital ichthyo-
siform erythroderma is an autosomal
dominant genodermatosis (OMIM
#113800) caused by mutations in the
suprabasal keratins (KRT) 1 and 10,
which manifests with erythroderma and
widespread blistering at birth, and
development of hyperkeratotic lesions
in later weeks (Brocq, 1902). Congeni-
tal epidermolytic epidermal naevi (EEN)
can be due to somatic mosaicism for
KRT1 or KRT10 gene mutations, and
can produce generalized EHK in the
next generation (Barker and Sachs,
1953; Lookingbill et al., 1984; Nazzaro
et al., 1990; Paller et al., 1994). We
report herein two unrelated children
with EHK, both born to a parent
affected with EEN, and prenatal diag-
noses in two successive pregnancies of
one of the patients suffering from EEN.
FAMILY 1
The proband was the first child born to
unrelated parents. At birth, the entire
skin was diffusely erythematous; large
areas of sloughing were present over
the trunk and limbs (Figure 1a). No
mucous lesions were observed. Histo-
logical and electron microscopal ex-
amination of a skin biopsy specimen
taken from the trunk showed a thick-
ened epidermis with an orthokeratotic
horny layer; clear and vacuolated cyto-
plasm with coarse keratohyalin gran-
ules and occasional tonofilament
clumps in keratinocytes of the granular
and upper spinous layers (Figure 1b).
Lower epidermal layer, and dermal-
epidermal junction were normal. On
this basis, the diagnosis of generalized
EHK was established. The patient de-
veloped febrile enterococcal infection,
and despite antibiotic therapy died from
sepsis on the 11th day of life. Examina-
tion of the proband’s mother revealed
several papular-keratotic, verrucoid le-
sions arranged in a linear-zosteriform
pattern over the left arm, forearm, and
hand (Figure 1c), over the posterior
aspect of the left thigh, the left part of
the chest, and the left paraombilical
abdominal wall. These lesions had
developed early in life. Histological
examination of verrucoid lesion from
the forearm showed similar findings,
although focal and less pronounced, to
those observed in the proband and was
diagnosed as a localized form of EHK
presenting clinically as EEN.
FAMILY 2
The proband was the second child born
to unrelated parents. At birth, the entire
skin was diffusely erythematous with
superficial blistering and palmoplantar
hyperkeratosis. No mucous lesions
were observed. Histological and elec-
tron microscopal examination of a skin
biopsy specimen revealed that the
horny layer was orthokeratotic, keratino-
cytes of the granular and upper spinous
layers had clear, vacuolated cytoplasm,
and coarse keratohyalin granules with
tonofilament clumps, diagnostic fea-
tures of EHK. The patient developed
sepsis and died on the 18th day of life
from sepsis with disseminated intravas-
cular coagulation. The proband’s father
presented from birth several verrucoı¨d
naevi, approximately symmetrically lo-
cated on the axilla, elbows, thigh,
knees, trunk, and back. On the back,
the disposition of the lesions was
Blaschkoı¨d. He also suffered from
palmoplantar keratoderma. Histologi-
cal findings include a thick orthoker-
atotic horny layer, vacuolated
cytoplasm of the keratinocytes from
the upper spinous and granular layers
containing large keratohyalin granules,
confirming the diagnosis of EEN.
MUTATION DETECTION AND
PRENATAL DIAGNOSIS
This study was approved by the
CCPPRB Toulouse I medical ethical
committee and was conducted accord-
ing to the Declaration of Helsinki
Principles.
After informed consent was ob-
tained, DNA was isolated from periph-
eral blood of the patients affected with
EHK, and from peripheral blood, non-
lesional, and lesional skin of their
affected parents. Direct sequencing of
KRT1 and KRT10 identified two novel
mutations (p.Phe191Ile in patient 1 and
p.Glu489Lys in patient 2) in the highly
conserved start and end, respectively,
of rod domains 1A and 2B of KRT1,
which are critical for the assembly of
keratin filaments (Albers and Fuchs,
1989; Coulombe and Fuchs, 1990). In
both affected parents, molecular ana-
lysis failed to detect the mutation in
peripheral blood and in normal skin,
whereas direct sequencing of DNA
isolated from parents’ lesional skin
identified a mosaicism for p.Glu489Lys
in family 2, but not for p.Phe191Ile in
family 1. However, in family 2, the
mutation could be detected as a weak
peak on electrophoregram (suggesting
that it was present in a minority of
cells); interpretation was facilitated be-
cause of previous identification in the
affected offspring (Figure 2). Taken to-
gether, these data show that molecular
& 2006 The Society for Investigative Dermatology www.jidonline.org 2715
LETTERS TO THE EDITOR
Abbreviations: EEN, epidermolytic epidermal naevus; EHK, epidermolytic hyperkeratosis; KRT, keratin
analysis should be performed on DNA
extracted from lesional skin in patients
affected with EEN. It may in some cases
identify the disease-causing mutation,
but a normal electrophoregram could
not rule out the presence of a mutation.
In family 1, prenatal diagnosis was
performed on two occasions after DNA
extraction from chorionic villus and
direct sequencing of KRT1 rod domain
1A. This analysis showed that neither
harbored the familial mutation and
healthy unaffected children were born
in each pregnancy. This is the first
report of prenatal diagnosis performed
in a patient affected with localized EEN.
Furthermore, segregation analysis of
closely KRT1-related microsatellite
markers in family 1 confirmed the
presence of germline mosaicism for a
KRT1 mutation in a patient with EEN by
showing that the mother had trans-
mitted three different KRT1 alleles to
her children (Table S1).
Epidermolytic naevi are clinically
indistinguishable from other types of
epidermal naevi, and can be differen-
tiated only by the specific histopatho-
logical aspect of EHK (Paller et al.,
1994). We therefore advocate that
histological study of epidermal naevi
should be regularly performed, espe-
cially in the case of widespread lesions.
Should histological examination show
signs of EHK, we believe that molecular
analysis of H1, 1A, and 2B domains of
KRT1 and KRT10, in which mutations
are clustered, should be proposed.
Identification of a keratin pathogenic
mutation would then permit prenatal
diagnosis to prevent transmission of a
generalized form of EHK. However, as
shown in this report, mutations could
remain difficult to identify in patients
with EEN even within lesional skin.
Failure to detect a mutation is not
sufficient to exclude the risk of trans-
mission of a severe generalized form of
EHK. In these families, the risk of
transmission of generalized EHK is
dependent on the presence of a germ-
inal mosaicism for KRT1 or KRT10
mutation, and on the proportion of
gametes harboring the mutation.
Whether systematic prenatal sequen-
cing of the conserved H1, 1A, and 2B
domains of KRT1 and KRT10 should be
performed for these patients’ pregnan-
cies with no offspring affected with EHK
remains to be discussed.
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Figure 1. Clinical features and ultrastructural analysis of patient 1 and his mother. (a) At birth the
proband’s skin was diffusely erythematous with superficial blistering and erosive lesions leading to diffuse
scaling. (b) Electronmicroscopic examination shows vacuolated keratinocytes of the upper epidermal
layers, containing tonofilament clumps; bar¼ 1.2mm. (c) The mother of patient 1 displays congenital
keratotic papula over the left hand, the arm, and forearm.
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Figure 2. Identification of KRT1 mutations. DNA samples extracted from lymphocytes from the index
patients in families 1 and 2, and from non-lesional and lesional skin from the affected parent displaying
epidermolytic epidermal naevi. (a) Family 1, (b) Family 2. In the affected parent of family 1, mutation p.
Phe191Ile (arrow) was not detected in normal and lesional skin, indicative of a small proportion of
mutated cells in the skin biopsy. In the affected parent of family 2, mutation pGlu489Lys (arrow) was not
present in non-lesional skin, whereas it could be detected in lesional skin (indicated by a asterisk).
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SUPPLEMENTARY MATERIAL
Table S1. Segregation analysis in family 1 of three
microsatellite markers flanking KRT1 and the
pathogenic mutation p.Phe191Ile demonstrating
germline mosaicism.
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TO THE EDITOR
Erythropoietic protoporphyrin (EPP;
OMIM 177000) is an inherited porphyr-
in metabolism disorder caused by de-
creased activity of the ferrochelatase
(FECH; E.C. 4.99.1.1.), the final enzyme
in the heme biosynthetic pathway. This
pathway catalyzes the insertion of fer-
rous iron into protoporphyrin IX, forming
heme. Clinically, excess protoporphyrin
accumulates in the skin, causing painful
photosensitivity in patients, which be-
gins in early childhood. In fewer than
10% of patients, the accumulation of
protoporphyrin in the liver may lead to
hepatic injury (Todd, 1994).
EPP’s mode of inheritance is primar-
ily autosomal-dominant; however, the
disease has a low clinical penetrance,
with less than 10% of mutation carriers
developing overt clinical symptoms
(Schneider-Yin et al., 2000). The acti-
vity of FECH in EPP patients is often
only 10–30% of the normal level, that
is, less than 50% of that which would
be expected from an autosomal-domi-
nant inheritable disease (Todd, 1994).
Gouya et al. (1996) revealed that the
EPP phenotype in an affected family
resulted from the coinheritance of both
a low-expressing and a mutant allele.
The mechanism responsible for the low
expression of FECH was recently de-
monstrated to be an IVS348T/C poly-
morphism that modulates the use of a
constitutive aberrant acceptor splice
site 63 bp upstream of the normal site
(Gouya et al., 2002). The T to C
mutation at position IVS348 was
found to result in 40% aberrantly
spliced mRNA by a process called
nonsense-mediated mRNA decay. The
C allele was present in 11% of the
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Figure 1. Pedigrees of families 1 and 2 with EPP. We investigated two EPP probands and their relatives.
EPP diagnosis was based on typical skin symptoms and biochemical data, including an elevated
concentration of erythrocyte protoporphyrin. The proband from family 1 is photosensitive owing to
increased erythrocyte protoporphyrin, and also exhibits liver dysfunction. The symptomatic members of
family 2, including the proband, exhibit only photosensitivity. The solid symbols refer to symptomatic
individuals, and the probands are indicated by arrows. WT, wild-type. T and C represent wild-type
IVS348T and splice site modulator IVS348C, respectively. ND, not determined.
Abbreviations: EPP, erythropoietic protoporphyrin; FECH, ferrochelatase
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